Biotage

Board/Management Information • Oct 27, 2010

Press release Biotage AB

Contact: SE-753 18 Uppsala Torben Jörgensen, President and CEO Tel+46 18 56 59 00 Tel: +46 707 49 05 84, torben.jorgensen@biotage.com www.biotage.com

Uppsala October 27 , 2010

Biotage AB Nomination Committee

A Nomination Committee consisting of shareholder representatives and the Chairman of the Board of Directors has been formed for Biotage AB. The Nomination Committee shall, before the Annual General Meeting 2011, prepare proposals for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual General Meeting, the determination of fees and matters pertaining thereto.

The members of the Nomination Committee are:

Staffan Josephson, Investor Growth Capital

Anders Walldov, Brohuvudet AB and direct holding

Tommy Jacobsson, Varenne AB

Ove Mattsson, Chairman of the Board, direct holding and holding by endowment insurance

Shareholders wishing to submit a proposal for members of the Board of Directors may do so sending e-mail to the Chairman of the Board of Directors of Biotage AB at: info@biotage.com

Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at CET 16.30 am on October 27, 2010.

About Biotage

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world's largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the US, UK and Japan. Biotage has 269 employees and had sales of 394.1 MSEK in

Kungsgatan 76

2009. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com